by Gonzalo Payan | Oct 22, 2018
MAX BioPharma is pleased to announce that it has been awarded a Phase IIB grant in continuation of the successful completion of our Phase II award to develop an effective compound for intervention in osteoporosis by stimulating bone formation in patients that have...by Gonzalo Payan | Sep 11, 2018
MAX BioPharma selected to present at the LA BioMed Innovation Showcase to be held on September 13th, 2018 in Manhattan Beach, California.by Gonzalo Payan | Sep 7, 2018
MAX BioPharma was recently selected into NIH’s Commercialization Accelerator Program (CAP). CAP is a highly competitive program that enables participants to establish market and customer relevance, build commercial relationships, and focus on revenue...by Gonzalo Payan | Sep 7, 2018
Available drug treatments for hair loss are modestly effective at best and often plagued by unpleasant side effects. In male pattern baldness, hormonal and other factors lead to a shortened growth (anagen) phase of the hair follicle, resulting in deactivated hair stem...by Gonzalo Payan | Jun 15, 2018
MAX BioPharma Awarded $1.7 Million to Fight Osteoporosis. For more details, follow this link to the LA Business Journal